Clinical Trial Update: Efficacy of Topical Tacrolimus in Different Subtypes With Cutaneous Lupus Erythematosus (CLE) [Phase 2]

View source ↗

Summary

Phase 2 trial reports efficacy data for topical tacrolimus across different subtypes of cutaneous lupus erythematosus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Lupus Erythematosus

Drugs mentioned

• Tacrolimus (Tacrolimus)

Snippet

Sponsor: Heinrich-Heine University, Duesseldorf | Conditions: Cutaneous Lupus Erythematosus | Phase 2 | Status: COMPLETED